Dr. Jon P. Mochel is a Professor of Systems Pharmacology in the Department of Pathology and the Founding Director of the Precision One Health Initiative at the University of Georgia (USA). He has an extensive background in Clinical and Basic Pharmacology and Toxicology and is a Board-Certified Veterinary Pharmacologist and Toxicologist (DECVPT). Dr. Mochel holds advanced degrees in Pharmacology (MS), Pharmacokinetics (MS), and Applied Mathematical Modeling (PhD). His research focuses on the effects of therapeutic drugs in complex biological systems, such as the heart and kidneys. Dr. Mochel is a Fellow of the American Academy of Veterinary Pharmacology and Therapeutics and serves as an ad hoc reviewer for several public organizations, including the US National Science Foundation, the National Institute of Standards and Technology, the UK Medical Research Council, and the CNRS/INSERM ATIP-Avenir Program. His contributions have earned him the Early Career (2019) and Mid-Career Achievement (2022) Research Awards from Iowa State University’s College of Veterinary Medicine, as well as the American Academy of Veterinary Pharmacology Research Award (2022). Dr. Mochel currently serves as President of the European Association of Veterinary Pharmacology and Toxicology (EAVPT) and as the President Elect of the European College of Veterinary Pharmacology and Toxicology (ECVPT). He has authored over 160 peer-reviewed publications in select biomedical journals and has secured more than $17 million in research funding as a principal investigator ($8,000,673) or co-investigator ($9,187,951) in the past eight years. As of 2024, Dr. Mochel is recognized as one of the "World's Top 2%" scientists on Stanford University's list.